baber/WOPTO huggingface dataset:
Patent CA-2292065-A1 (CA)
Title: Closed system meter having address correction capabilities
Inventor: QUINE DOUGLAS B
IPC: G07B17/00
Filed: 1999-12-13
Abstract: System and method are provided for generating a Postnet bar code with a closed system metering device. Before an indicium is printed on a mailpiece, a scanner is used to scan recipient address information printed on a mailpiece. Using the scanned information, the metering device determines the Postnet bar code corresponding to the scanned information. A check is then made to determine if the recipient address information has changed from the scanned information. If it has not changed, the metering device prints the postal code on the mailpiece. When the recipient address information has changed, the metering device generates a corrected postal code and prints the corrected postal code and the corrected address on the mailpiece.
Patent CA-2294891-A1 (CA)
Title: Multilayer abuse resistant high barrier packaging film
Inventor: SHAH GAUTAM P
IPC: B32B27/20
Filed: 1998-06-25
Abstract: A multilayer film exhibits exceptional N2-, O2-, and CO2-barrier without containing metal foil. The film can also be provided with high moisturebarrier characteristics as well as high opacity to light, and can also be made very abuse-resistant, and can be especially suited for the packaging of relatively heavy rolls of undeveloped photographic film. A preferred opaque multilayer film is especially suited to packaging light-sensitive products such as photographic film and photographic paper, and has an outer seal layer and at least one inner layer containing carbon black, preferably two inner layers containing carbon black. The presence of the carbon black in one or more inner film layer prevents the carbon black from rubbing off of the film on film-making and packaging equipment, as well as a product packaged in the film. Articles such as bags, casings, and pouches can be made from the film.
Patent CA-2296685-A1 (CA)
Inventor: KERRELS PIERRE RAYMOND
IPC: E01C5/08
Filed: 1999-04-28
Abstract: The invention concerns a joint comprising at least two elements with shaped profiles arranged to fit into each other mutually such as a male part and at least one female part, each of them being integral with the edges of two adjacent slabs. One slab (22) edge is provided having a substantially L-shaped female profile (34) whereof the vertical branch (27) extends along the edge up to the slab (22) upper surface ridge and the base branch (35) extends inwards of the slab (22) and folded back on itself downwards to form a double branch (27) extending parallel to the base branch (35) leaving between them a reduced space (36) wherein part of the male profile (32) can be engaged.
Patent CA-2299200-A1 (CA)
Title: Process for the preparation of endo-nortropine using 8-benzyl-nortropan-3-one perchlorate as the intermediate, as well as the latter salt
Inventor: SACHSE ROLF
IPC: C07D451/06
Filed: 2000-02-16
Abstract: The invention relates to a process for the preparation of endo-nortropine using 8-benzyl-nortropan-3-one perchlorate, as well as the latter product.      Endo-nortropine is the key product for the production of important azonia-spironortropanol esters, which are used as pharmaceuticals, particularly spasmolytics. There are three different synthesis methods for the preparation of said intermediate, which lead to different disadvantages. These problems are obviated by the present invention through the two-stage treatment of 8-benzyl-nortropan-3-one perchlorate with catalytically activated hydrogen, the starting product initially being prehydrogenated in aqueous suspension and at atmospheric pressure and ambient temperature with a palladium catalyst, at the end of the reaction the catalyst is recovered by filtration, the filtrate is passed over an anion exchanger and the now alkaline reacting solution is rendered turbulent at 1000 to 1500 r.p.m. with hydrogen activated by Raney nickel at atmospheric pressure and ambient temperature. This new synthesis method using the novel perchlorate salt as as intermediate is extremely economic and environmentally friendly and supplies substantially completely stereoselectively the desired endo-form of nortropine.
Patent CA-2300698-A1 (CA)
Inventor: BURCZYK ANDREW F H
IPC: A62D3/35
Filed: 2000-02-14
Abstract: A decontamination formulation is provided which is effective against a broad spectrum of chemical and biological warfare agents and radioactive dusts, comprising an active decontamination agent, a co-solvent, a buffer system to optimize the initial reaction pH above 8.5 and more preferably in the range of to 11 for favoring oxidation of VX and HD and hydrolysis of G agents, and a surfactant similar to fire-fighting foaming agent. Formulations comprise, in water by weight, 1 % to 15% of a hydrated chloroisocyanuric acid salt, 1% to 10% of a polypropylene glycol co-solvent, 1 % to 15% surfactant and a buffer system to initially maintain said formulation at a pH from about 11 to about 8.5 for sufficient duration to effect decontamination. The formulation can be provided in kit form or concentrate form, be prepared, in part, in advance or on site, and be dispensed in foam form which aids in coating and adhering of the decontamination formulation to contaminated surfaces. All ingredients can be pumped through a foam nozzle or water, co-solvent and surfactant can be pumped to the nozzle with solutions of buffer and of active ingredient being introduced at the nozzle for minimizing pump exposure.
Patent CA-2301304-A1 (CA)
Inventor: STRUENGMANN ANDREAS
IPC: A61K47/40
Filed: 1998-08-27
Abstract: Compositions pharmaceutiques contenant un agent anti-inflammatoire de type carboxamide énolique, désigné meloxicam, présentant des caractéristiques améliorées de mouillabilité, de solubilité aqueuse, de comportement à la dissolution sur une plage importante de pH et dont la préparation consiste à modifier la structure cristalline du médicament par homogénéisation mécanique sèche ou humide avec deux constituants supplémentaires, dont l'un est sélectionné dans un groupe oligo améliorant la dissolution ou consiste en un agent d'alcalinisation. Ces formulations permettent d'améliorer la biodisponibilité et l'efficacité de meloxicam.
Patent CA-2303321-A1 (CA)
Title: Treating agent for a sheet surface and a paper for ink jet printing
Inventor: ONO MOTOSUKE
IPC: C08F261/04
Filed: 1998-09-10
Abstract: There is provided a treating agent for a sheet surface comprising a graft copolymer composed of a back bone polymer and branch polymer, either of which is a polymer having vinyl alcohol units, and the other of which is a polymer having cationic groups, the treating agent is applied onto a pulp sheet or plastic sheet, and the coated sheet is used in ink jet printing. Cationic groups are introduced by graft copolymerization using di(meth)allylamine-based and/or (meth)acryl-based monomer.  Alternatively, the graft copolymer of the present invention is obtained by grafting N-vinylcarboxylic acid amide monomer followed by hydrolysis thereof. A formula weight ratio of vinylalcohol units and the introduced cationic groups of 1:20 to 2:1 is preferable in terms of balanced performance.
Patent CA-2304068-A1 (CA)
Title: Vertical climbing wall
Inventor: POPP RICHARD R
IPC: A63B69/00
Filed: 2000-04-06
Abstract: The present invention relates to a climbing wall for simulating outdoor rock climbing activity. The climbing wall includes a front surface, a rear surface and an intermediate portion reaching between the front surface and the rear surface. The intermediate portion defines one or more openings which extend through the climbing wall. The openings are located in positions that allow a child to travel safely around on the climbing wall. The intermediate portion also includes a grip projecting outward from the front surface and preferably the rear surface of the climbing wall. The grips are designed to allow a child to maneuver safely around the climbing wall.
Patent CA-2304402-A1 (CA)
Inventor: NITECKI JEAN-PIERRE
IPC: B67D7/04
Filed: 2000-03-30
Abstract: ? Installation de distribution d'hydrocarbures liquides équipée d'un moyen de récupération des vapeurs. Installation comprenant un séparateur vapeur/liquide (8) muni d'une chambre de réception (81) pour recueillir le liquide, ce séparateur étant monté dans le circuit de récupération des vapeurs en amont du contrôleur de débit de vapeur (9), et la chambre de récupération (81) est reliée à un tube de purge (85) dont l'entrée est munie d'un clapet anti-retour (86).
Patent CA-2304529-A1 (CA)
Title: Reactive oligomers for isocyanate coatings
Inventor: CORCORAN PATRICK HENRY
IPC: C09D175/06
Filed: 1998-11-03
Abstract: The invention is directed to a two-pack solvent-based ambient curable coating composition comprising a binder of a hydroxyl and cross-linking components. The hydroxyl component includes a linear or branched cycloaliphatic moietycontaining reactive oligomer or blend of oligomers with a weight average molecular weight not exceeding 3,000, a polydispersity not exceeding about 1.7 with at least 2 hydroxyl groups, at least 1, on average, being a primary hydroxyl group. The reactive oligomer is formed by the reaction of an oligomeric acid with monofunctional epoxy. The cross-linking component includes one or more of an oligomeric cross-linker containing at least 2 isocyanate groups. The coating composition of the invention is particularly suited in automotive refinish coatings.
Patent CA-2304818-A1 (CA)
Title: Therapeutic pad and method
Inventor: OWENS BYRON C
IPC: A61F7/00
Filed: 1991-02-25
Abstract: A therapeutic pad for heating or cooling has a liquid absorbent to prevent liquid leakage in the event the sealed envelope of the pad is ruptured. The method of forming the pad includes vacuuming the thermoplastic envelope prior to sealing.      The pad can be used alone or with a comforter to provide warmth or to remove heat from the body of the user.
Patent CA-2308022-A1 (CA)
Title: Spatial digitizer
Inventor: KIELLAND PETER
IPC: G06F3/0346
Filed: 2000-05-15
Abstract: A handheld pointer-member, freely moveable within an orthogonally referenced three-dimensional workspace. Six rotational encoder assemblies, electronically coupled to a host computer, are affixed in three pairs that form a triangle.  Six tensioned cables are guided through six holes near each of the six rotational encoder assemblies. Each cable drivingly engages an encoder's rotateable input shaft, thereby digitizing all changes in the cable's extended length into the host computer. One cable from each vertex of the triangle is affixed to one of two cable attachment points spaced apart on the pointer-member. The host computer continuously trilaterates the XYZ coordinates of both cable attachment-points using measured changes in the six cable lengths. The pitch and yaw attitude between the two cable attachment points is derived and used to compute the coordinates of the tips of the pointer-member. The user guides the pointer-member's tips over an object's surface, thereby digitizing its shape into the host computer.
Patent CA-2312570-A1 (CA)
Title: Improved polymer-sulphur-polymer coated fertilizers
Inventor: HARGROVE GARRARD L
IPC: C05G3/00
Filed: 2000-06-27
Abstract: The present invention described a polymer coated fertilizer, such as urea, subsequently coated with a layer of sulfur and thereafter a further coating of polymer. Preferably, the polymer coatings are formed by the direct in situ co-polymerization of the components of the polymer on the fertilizer and on the sulfur coating.    The compositions provide positive controlled release characteristics, are abrasion and impact resistant and are substantially more economical to produce than polymer coated fertilizers.
Patent CA-2316097-A1 (CA)
Inventor: GOTTLING JOSEF
IPC: B41F13/44
Filed: 2000-08-10
Abstract: A printing unit is provided for a web fed printing machine having at least two cylinders where at least one of the cylinders is adjustable with respect to another of the cylinders; a machine frame having at least one load bearing wall arranged laterally beside an end of the cylinders; a drive motor corresponding to each cylinder; at least one guide element operably attached to the load bearing wall at a surface of the load bearing wall that runs perpendicular to a plane through the end faces of the cylinders; and a plurality of carriages attached to the guide element. At least one of the cylinders is connected to the carriages so that a distance from another of the cylinders can be adjusted.
Patent CA-2318316-A1 (CA)
Title: An apparatus for use in connection with removal of elements, especially exogenous antibodies, from blood or plasma
Inventor: SANDBERG BENGT E B
IPC: A61M1/36
Filed: 1999-01-14
Abstract: An apparatus for use in connection with removal of elements, especially exogenous antibodies, from blood or plasma flowing in an extracorporeal blood circulation system of a patient, where said apparatus comprises a container (1). This container is adapted to receive an adsorbent and comprises an inlet (15) and an outlet (16) which are adapted to be connected to an inlet conduit (19) and an outlet conduit (20), respectively, forming part of the blood circulation system. The container (1) comprises an inlet chamber (31), and adsorption chamber (32) adapted to receive the adsorbent and an outlet chamber (33). These chambers are arranged in sequence when seen in the flow direction of the blood or the plasma through the container (1) and are separated by means of filter units (11, 12) allowing passage of the blood or the plasma. The inlet (15) and the outlet (16) are arranged adjacent one another in connection with a common movable valve means (21).      The valve means is adapted so has in a first position to connect the inlet (15) and the outlet (16) directly with their respective passages (28, 29) in the container wall (4) and so as in a second position to connect said inlet (15) and said outlet (16) with their respective ends of a bypass-forming channel (34) in the container wall (4). The passage (28) associated with the inlet communicates with a transfer channel (30) ending in the inlet chamber (31), whereas the passage (29) associated with the outlet (16) is open into the outlet chamber (33).
Patent CA-2319615-A1 (CA)
Inventor: SUORSA VEIJO T
IPC: A61B8/12
Filed: 1999-02-03
Abstract: A catheter system comprises a catheter body (72) having a distal end (74), a proximal end (76) and a working lumen (78). A cable (80) is disposed within the working lumen (78). A plurality of transducer elements, configured in an annular array (10), are operably attached to a distal end of the cable (80).
Patent CA-2320905-A1 (CA)
Title: A shelf device with feeding arrangement
Inventor: BRODIN SEBASTIAN
IPC: A47F5/00
Filed: 1999-02-15
Abstract: The invention relates to a shelf device, which preferably is arranged to be used in shops or storerooms. The shelf device is arranged to receive a plurality of objects (2) in such a way that these are provided essentially one after the other in a row with a first of these objects (2) in a front position (3) of the shelf device. The first object (2) is in this position arranged to be removable from the shelf device, for example, by a customer. The shelf device comprises means arranged to detect when an object (2) is removed from said position (3) and thereafter initiate a feeding of a new object (2) to said position (3).  Furthermore, this means is arranged to initiate said feeding with a time delay after an object (2) has been removed from said position (3).
Patent CA-2327942-A1 (CA)
Title: Collapsible container
Inventor: OGDEN DON M U
IPC: B65D6/26
Filed: 2000-12-08
Abstract: A collapsible container for storage and transport of produce or other goods is provided. In one embodiment, there is provided a five piece collapsible container with a base and four pivotable walls. Each of the four walls are outwardly collapsible to facilitate washing, and inwardly collapsible for compact storage. A latch mechanism is provided at each of the four points where two sidewalls abut each other providing a rigid assembled container. Attached to each latch mechanism is an actuating member with a grip. There is a latch mechanism on each side of each of two opposing sidewalls and latch actuators with grips that in close proximity to each other. The two grips allow the operator to disengage both latches integral with one side of the container with one hand. Similarly, when collapsing the container from assembled position, all four latches can be disengaged with each hand at respective pairs of grips. The latches are readily disengageable while providing a rigid assembled container.
Patent CA-2328262-A1 (CA)
Inventor: KRUG PETER
IPC: G02B5/18
Filed: 2000-12-14
Abstract: The Bragg grating manufacturing process can be accomplished efficiently by first pre-selecting only functional devices to save time and also by performing steps in the process on the same equipment and in parallel so that the operations are performed simultaneously rather than sequentially.
Patent CA-2328915-A1 (CA)
Title: Remotely controlled door lock system and method
Inventor: KALAYJIAN NICHOLAS R
IPC: E05B47/02
Filed: 1999-04-16
Abstract: A remote door lock system (10) including a radio frequency transmitter (12) for transmitting a coded sequence (14), a battery-powered controller (16) including a radio frequency receiver (20) recepted to the coded sequence, and a lock mechanism (22) including actuator (24) and a bolt (26) coupled to the actuator. The controller decodes the coded sequence during an awake mode and develops an actuator signal if the coded sequence is proper. The controller has a sleep mode that alternates with the wake mode to reduce the overall power consumption. The actuator of the lock (10) mechanism is responsive to the actuator signal, and is operative to assert a force on the bolt to lock or unlock the door (34). The controller preferably includes a low power LED  driver circuit (112) including a pulse generator powering a flyback converter to control the output of the LED.
Patent CA-2331064-A1 (CA)
Inventor: ZASADNY KENNETH R
IPC: A61K51/00
Filed: 1999-06-04
Abstract: A patient-specific optimally effective radiation dose for administration of a radiopharmaceutical to a patient for treatment of a disease may be established by basing the calculation of the appropriate therapeutic dose on factors such as the desired total body dose, the maximum tolerated dose, the typical clearance profile of the radiopharmaceutical, the patient's mass or maximum effective mass, and the patient-specific residence time of the radiopharmaceutical or an analog in the whole body of the patient. The use of the method allows for treatment of a patient with an appropriate dose which is maximally effective against the disease yet minimally toxic. The determination of a patient-specific therapeutic dose may be assisted by the use of a software program set to the particular parameters of the radiopharmaceutical.
Patent CA-2331577-A1 (CA)
Title: Optical communication device
Inventor: KUHARA YOSHIKI
IPC: H01S5/022
Filed: 2001-01-18
Abstract: An optical communication device (an LD module or an LD/PD module) having a flat substrate, a light waveguide layer formed upon the substrate with a core for guiding signal LD light, an LD bonded upon a part of the substrate without the whole or a part of the light waveguide layer for producing signal front light and monitoring rear light, a path conversion groove being perforated along the core on the substrate behind the LD and having slanting walls for reflecting rear light emitted backward from the LD, a bottom- or top-incidence type PD bonded upon the light waveguide layer over the path conversion groove for monitoring the LD power by detecting the LD rear light reflected by the path conversion groove. Since the PD level is higher than the LD by the thickness of the light waveguide layer, the monitoring PD can sense more than 50% of the LD rear light.
Patent CA-2331761-A1 (CA)
Inventor: GOMI SHINYA
IPC: A61K35/12
Filed: 1999-06-24
Abstract: Tumor antigen peptides originating in cyclophilin B or derivatives thereof having functionally equivalent characteristics thereto; remedies, preventive s or diagnostics for tumors containing as the active ingredient these tumor antigen peptides, derivatives thereof, cyclophilin or peptide fragments thereof, or genes encoding the cyclophilin or peptides fragments thereof; us e of the above substances in treating tumors in vitro; and antibodies against the above tumor antigen peptides or derivatives thereof.
Patent CA-2338712-A1 (CA)
Title: Utilisation de composes a base de creatine pour traiter les cellules et les tissus osseux et cartilagineux
Inventor: GERBER ISABEL
IPC: A61K31/205
Filed: 1998-07-28
Abstract: L'invention concerne une méthode, une composition et l'utilisation de ladite composition pour traiter, chez l'animal et chez l'homme, les défauts osseux ou cartilagineux d'origine traumatique ou chirurgicale. La méthode consiste à administrer des composés à base de créatine, y compris leurs analogues ou leurs sels pharmaceutiquement acceptables. Le traitement selon cette méthode accélère et améliore, chez l'animal et chez l'homme, la réparation des défauts du tissu osseux ou cartilagineux d'origine traumatique ou chirurgicale, et notamment l'acceptation et la fixation des implants artificiels. Ce traitement peut être soit thérapeutique chez les malades, soit préventif chez les sujets sains, soit gériatrique chez les personnes âgées.
Patent CA-2340454-A1 (CA)
Inventor: BROWN DEARG SUTHERLAND
IPC: A61P17/06
Filed: 1999-09-21
Abstract: L'invention concerne des dérivés d'amide représentés par la formule I I dans laquelle R?3¿ représente alkyle C¿1?-C¿6? ou halogéno; m est 0-3, p est 0-2 et q est 0-4; chacun de R?1¿ et R?2¿ représente un groupe tel qu'hydroxy, halogéno, trifluorométhyle et cyano; R?4¿ représente un groupe basique tel qu'amino, alkylamino C¿1?-C¿6?, dialkylamino C¿1?-C¿6?, dialkylamino C¿1?-C¿6?- alkyle C¿1?-C¿6?, dialkylamino C¿1?-C¿6?-alkoxy C¿2?-C¿6?, hétéroaryle, hétéroaryloxy, hétéroaryle-alkoxy C¿1?-C¿6?, hétérocyclyle, hétérocyclyloxy et hétérocyclyl-alkoxy C¿1?-C¿6?; et Q?2¿ représente un groupe tel qu'hétéroaryle, hétéroaryloxy ou hétéroaryl-alkoxy C¿1?-C¿6? éventuellement substitué; ou ses sels acceptables sur le plan pharmaceutique ou esters pouvant être clivés in vivo; procédés servant à les préparer, compositions pharmaceutiques les contenant et leur utilisation pour traiter des maladies ou états pathologiques dans lesquels les cytokines jouent le rôle d'intermédiaire.
Patent CA-2340882-A1 (CA)
Inventor: LINARES R GERMAN
IPC: G07D7/00
Filed: 1999-08-17
Abstract: A method for encoding, on an imprintable medium, identification information for identifying the imprintable medium in a manner detectable by a print- monitoring system includes the steps of defining an identification pattern. The identification pattern is imprinted on a print control region so as to b e relatively inconspicuous to an unaided human reviewer of the printed matter while remaining detectable to a print monitoring system. The method includes  the step of imprinting, at a plurality of locations in the print control region, a plurality of bit characters detectable by the print control system . The spatial distribution of the bit characters encodes information about the  identity of the document.